USP <62> Objectionable Organisms in Botanical Powders: What Your Total Plate Count Won't Tell You

Every week, botanical raw material lots arrive at receiving docks across the Midwest carrying COAs that look perfectly clean. Total aerobic microbial count under 10,000 CFU/g. Total yeast and mold under 1,000 CFU/g. Numbers that, on paper, suggest a safe, compliant ingredient. And yet, when an independent analytical testing laboratory runs USP <62> confirmatory testing on those same lots, a meaningful subset come back flagging for Salmonella species, E. coli, or bile-tolerant gram-negative bacteria.

This is not always a supplier fraud story. More often, it’s a testing methodology story. And if you’re a supplement formulator or contract manufacturer sourcing botanical powders, understanding the gap between USP <61> and USP <62> could be the difference between a clean production run and an FDA warning letter.

What USP <61> and USP <62> Actually Test For — and Why Both Matter

The two chapters are routinely discussed as a package, but they answer fundamentally different questions. USP <61> (Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests) tells you how many microorganisms are present. It produces a total aerobic microbial count (TAMC) and a total yeast and mold count (TYMC). Useful signals. But they’re population-level numbers — they can’t tell you who’s in the room, only how crowded it is.

USP <62> (Microbiological Examination of Nonsterile Products: Tests for Specified Microorganisms) tells you which organisms are present. Specifically, it screens for a defined list of pathogens and indicator organisms whose presence — even at numbers too small to influence a plate count — represents a direct hazard:

• Salmonella species — absence required in 10 g for oral-route botanical products
• Escherichia coli — absence required in 1 g for oral non-aqueous botanicals; criteria vary by dosage category
• Bile-tolerant gram-negative bacteria (BTGN) — ≤10² CFU/g for oral non-aqueous products
• Staphylococcus aureus — absence in 1 g
• Pseudomonas aeruginosa — absence in 1 g
• Clostridium spp. — absence in 1 g, with particular relevance for raw materials of natural origin

Here’s the critical point: Salmonella causes illness at an inoculum of 20–100 cells. A lot with a TAMC of 8,500 CFU/g — a perfectly “clean” plate count result — could contain a localized cluster of Salmonella at 50 CFU/g in a particular area of the drum that the enumeration test never detected. The selective enrichment methods built into USP <62> are specifically designed to amplify that signal from background noise. Plate count testing is not.

Why Botanical Powders Carry a Categorically Higher Risk Profile

Not all raw materials enter the supply chain the same way. Botanical powders have a risk profile that sets them apart from synthetic APIs, food-grade commodity starches, or even pharmaceutical excipients — and four factors drive it.

The soil-plant interface. Most medicinal herbs are harvested in contact with agricultural soil, and soil is a natural reservoir for both Salmonella and spore-forming Clostridium species. Clostridium spores in particular survive conventional drying and milling processes intact. We’ve seen Clostridium perfringens flagged in dried ashwagandha root powder, valerian root, and slippery elm bark — materials that arrived with clean total plate counts but were carrying viable spores that no enumeration test would have surfaced.

Animal manure contamination. In both conventional and organic herbal agriculture, manure application is standard practice. Root herbs — turmeric, ginger, burdock root, dandelion root — are particularly vulnerable because they grow directly in amended soil. Studies published in the Journal of Food Protection have documented E. coli O157:H7 in dried botanical materials from overseas suppliers even when the accompanying COAs showed passing total coliform counts. The manure is applied months before harvest; what remains in the finished powder is often too dilute to affect total counts but sufficient to constitute a hazardous presence.

Inadequate drying temperatures. Many botanical powders sourced from smallholder farming operations are dried at 50–60°C — temperatures that destroy vegetative cells but not heat-resistant spores, and that are inconsistently applied across large batches. Full thermal inactivation of Salmonella in root and bark materials typically requires sustained temperatures above 75°C throughout the entire matrix, not just surface pasteurization. Air-drying, sun-drying, and low-temperature cabinet drying — all common in overseas production — frequently fall short.

Supply chain length and transitions. Chicago-area supplement brands typically source botanical raw materials from domestic brokers who aggregate from overseas farms across India, China, Southeast Asia, and Eastern Europe. By the time a 25-kg drum reaches a Midwest warehouse, it has changed hands three to five times and traveled through multiple humidity and temperature environments. Each transition is a potential microbial amplification event. Transit holds, customs delays, and damaged packaging during freight are particularly high-risk scenarios.

What 21 CFR Part 111 Requires — and Where Most Brands Fall Short

Under the DSHEA cGMP rule, 21 CFR Part 111, every dietary supplement manufacturer must establish component specifications covering identity, purity, strength, and composition; test each lot of every dietary ingredient against those specifications before use; and maintain records demonstrating that testing was completed and results were reviewed prior to lot release.

Section 111.75(a)(1)(i) explicitly requires testing to confirm that specifications are met. For companies relying on a supplier’s COA in lieu of independent testing, Section 111.75(c) sets strict conditions: you must have validated that specific supplier through documented independent testing — not a one-time check, but a systematic process — and you must still conduct independent identity verification on every incoming lot regardless.

The gap we see most consistently: raw material component specifications at Midwest supplement companies include TAMC and TYMC limits but have never documented Salmonella absence, E. coli absence, or BTGN limits as acceptance criteria. If those parameters aren’t in your specs, you have no documented basis to test for them — and no documented basis to release the lot based on compliance. FDA 483 observations routinely cite exactly this omission.

A second gap: companies that have validated a supplier once, several years ago, and have never requalified despite supplier audits showing changes in sourcing geography or manufacturing site. Supplier qualification is not a one-time event.

How USP <62> Testing Works at an Accredited Analytical Testing Laboratory

Running USP <62> correctly isn’t a matter of plating a swab and checking back in 48 hours. The Salmonella pathway alone involves multiple sequential enrichment steps:

1. Pre-enrichment in buffered peptone water (BPW) at 37°C for 18–24 hours — this step allows injured or stressed Salmonella cells to recover before exposure to selective pressure
2. Selective enrichment in Rappaport-Vassiliadis (RV) broth at 41.5°C and Müller-Kauffmann tetrathionate broth (MKTTn) at 37°C, run simultaneously for 18–24 hours
3. Selective/differential plating on xylose lysine deoxycholate (XLD) agar and one additional selective medium (Hektoen Enteric or Brilliance Salmonella agar)
4. Biochemical and serological confirmation of all suspect colonies

A complete, confirmed Salmonella result takes 5–7 business days under this protocol. E. coli and bile-tolerant gram-negatives follow a shorter pathway — typically 3–5 days using membrane filtration or most probable number (MPN) methods with MacConkey selective agar.

An ISO 17025–accredited analytical testing laboratory maintains documented methods, trained and proficiency-tested analysts, traceable calibration records for all equipment, and an accreditation body’s oversight of all of this. That matters practically, not just philosophically: if you face an FDA audit or a product liability situation, the defensibility of your lot release decision depends on the quality of the testing records behind it. Method execution records from an accredited laboratory carry a different weight than a supplier’s in-house COA.

What the Data Says About Contamination Rates in Botanical Raw Materials

The industry-wide contamination picture is consistent across independent data sources. A 2018 analysis of more than 880 herbal supplement products surveyed in Germany found approximately 12% contained pathogenic or indicator organisms in excess of European limits. A 2020 survey of 90 botanical raw material lots received at North American contract manufacturing facilities found Salmonella present in 4.4% of sampled lots — roughly 1 in every 22 incoming shipments from typical broker channels.

In our receiving data, microbiology failures concentrate in three material categories: root powders from South Asian supply chains, whole-herb powders that include soil-contact plant parts, and materials that experienced a documented transit event — extended customs hold, temperature excursion, or damaged packaging during freight.

The operational implication is straightforward: a 4–5% Salmonella prevalence across incoming botanical lots means that if you’re bringing in 20 raw material shipments per month without independent USP <62> testing, you’re statistically likely to introduce a pathogen-positive lot into your manufacturing environment within 60 days.

A Practical Receiving Protocol for Midwest Supplement Brands

You don’t need to rebuild your quality system overnight to close this gap. Four steps that move the needle immediately:

1. Audit your component specifications. Pull the raw material specs for every botanical ingredient you source. If Salmonella absence (in 10 g), E. coli absence (in 1 g), and BTGN ≤100 CFU/g aren’t listed as acceptance criteria, add them before your next lot arrives. These are your pre-use testing parameters, and they need to be documented before they can be enforced.

2. Classify your highest-risk materials. Root powders, whole-herb powders, and materials from supply chains where upstream pasteurization is not verified should be your priority for independent USP <62> testing on every incoming lot. Standardized extracts from GMP-certified manufacturers with documented kill-step validation carry lower — but not zero — risk and may be appropriate candidates for periodic rather than lot-by-lot testing.

3. Build testing into your procurement lead time. USP <62> Salmonella results take 5–7 business days at a properly run analytical testing laboratory. If your current receiving process allows lots to move to production in 48–72 hours, that timeline doesn’t accommodate confirmatory microbiology. Either extend your supplier lead-time requirements or establish a formal quarantine hold procedure that keeps received lots in secure, temperature-controlled storage until testing is complete.

4. Document supplier validation status. Any supplier whose lots you’re releasing based on COA — rather than independent testing — should have a documented validation file showing the independent testing you used to establish their reliability, the number of clean consecutive lots, and the date of your last requalification. Suppliers without that file should be moved to independent lot-by-lot testing until the file exists.

The Math That Makes the Decision Easy

Independent USP <62> testing on an incoming botanical raw material lot runs between $180 and $350 per pathogen group per lot at most ISO 17025–accredited analytical testing laboratories, depending on sample matrix and turnaround time. A full Salmonella/E. coli/BTGN screen typically costs under $600.

The average cost of a Class II supplement recall in the United States now exceeds $10 million when you account for destroyed finished goods inventory, mandatory CAPA implementation, third-party audit requirements, regulatory response costs, and brand damage. A Salmonella-linked recall almost certainly triggers Class I classification, with costs that routinely reach $30 million or more for a mid-sized supplement brand.

The gap between those numbers — $600 per lot in testing versus eight figures in recall exposure — is where the conversation about “whether we can afford testing” stops making sense.

If you’re a Midwest supplement brand receiving botanical powders and your microbiology program ends at the total plate count, the question isn’t whether you should add USP <62> confirmatory testing. It’s how quickly you can implement it before the wrong lot clears quarantine.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days. Contact us

Related from our network

• ISO 17025 Testing for Supplement Raw Materials — Qalitex Laboratories runs the full USP <61>/<62> panel under ISO 17025 accreditation, with results accessible via certified CoA.
• Understanding cGMP Compliance for Supplement Manufacturers — How 21 CFR Part 111 applies to raw material receiving, testing, and lot release decisions at every production scale.